Programmable Assembly of Multivalent DNA-Protein Superstructures for Tumor Imaging and Targeted Therapy

© 2022 Wiley-VCH GmbH..

Programmable DNA materials hold great potential in biochemical and biomedical researches, yet the complicated synthesis, and the low stability and targeting efficacy in complex biological milieu limit their clinical translations. Here we show a one-pot assembly of DNA-protein superstructures as drug vehicles with specifically high affinity and stability for targeted therapy. This is achieved by biomimetic assembly of programmable polymer DNA wire into densely packed DNA nanosphere with an alkaline protein, protamine. Multivalent DNA nanostructures encoded with different types and densities of aptamers exhibit high affinity to targeted cells through polyvalent interaction. Our results show high cancer cell selectivity, reduced side effect, excellent therapeutic efficacy, and sensitive tumor imaging in both subcutaneous and orthotopic non-small-cell lung cancer murine models. This biomimetic assembly approach provides practical DNA nanomaterials for further clinical trials and may advance oligonucleotide drug delivery.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:61

Enthalten in:

Angewandte Chemie (International ed. in English) - 61(2022), 44 vom: 02. Nov., Seite e202211505

Sprache:

Englisch

Beteiligte Personen:

Xu, Zhen [VerfasserIn]
Shi, Tianhui [VerfasserIn]
Mo, Fengye [VerfasserIn]
Yu, Wenqian [VerfasserIn]
Shen, Yu [VerfasserIn]
Jiang, Qunying [VerfasserIn]
Wang, Fuan [VerfasserIn]
Liu, Xiaoqing [VerfasserIn]

Links:

Volltext

Themen:

9007-49-2
Cancer Therapy
DNA
DNA Nanostructures
Drug Delivery
Journal Article
Multivalency
Oligonucleotides
Polymers
Protamines
Research Support, Non-U.S. Gov't
Self-Assembly

Anmerkungen:

Date Completed 27.10.2022

Date Revised 29.11.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/anie.202211505

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM346000203